AUTOZONE INC
AZOAbout the company
AutoZone, Inc. operates as a retailer and distributor of automotive replacement parts and accessories in the United States, Mexico, and Brazil. The company offers a product line for cars, sport utility vehicles, vans, and light duty trucks, including new and remanufactured automotive hard parts, maintenance items, accessories, and non-automotive products.
Investment snapshot
Positive
2
BUY / PASS
Neutral / negative
6 / 8
NEUTRAL / FAIL
Median fair value
$1894.49
-41.9% vs price
Models with upside
0 / 17
Positive margin of safety
Strongest signal
6 of 8 pass — Lynch and Sleep object
Key risk
AZO overvalued: all 9 models price fair value below $3259.70 (median $1894.49)
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | NEUTRAL | FAIL | BUY · Rank #486 (Top 15.7%) | NEUTRAL | FAIL | NEUTRAL | FAIL | NEUTRAL | FAIL | PASS | FAIL | BUY | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||
| Margin of Safety | N/A | -16.6% | -49.7% | -96.3% | N/A | -52.8% | -89.4% | -100.6% | N/A | -139.3% | -72.1% | -70.0% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2025 · Balance sheet at 2026-05-09 Latest source filing: 2026-06-12 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2025-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-05-09 Latest source filing: 2026-06-12 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2025-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2025-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-05-09 · Market data at 2026-11-01 Latest source filing: 2026-06-12 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · Balance sheet at 2026-05-09 Latest source filing: 2026-06-12 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2025-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · Balance sheet at 2026-05-09 Latest source filing: 2026-06-12 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2025-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-05-09 · Market data at 2026-11-01 Latest source filing: 2026-06-12 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-05-09 Latest source filing: 2026-06-12 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2025-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-05-09 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-06-12 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2025-10-27 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-05-09 Latest source filing: 2026-06-12 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2025-10-27 Score computed: 2026-11-14 |
Where It Passes
- Growth75% pass✓ 11✗ 2▾
6 of 8 pass — Lynch and Sleep object
EPS Growth (3-yr avg, 10-yr window)8251.9%✓Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)1.50✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR15.0%✓Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthN/A (no inventory)✓LynchInventory growth < Revenue growthEPS Growth Direction$1.48 (1998) -> $144.87 (2025)✓DremanPositive over recent yearsEPS CAGR18.5% CAGR over 27 years✓Dreman> 5% annualizedPositive Net Income Frequency28/28 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth5.9%✓Ackman>= 5%Positive EPS Growth Frequency4/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR15.0% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 52.0% -> 52.6%, operating margin 19.9% -> 19.1%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR8.4%✓SleepCAGR > 7%3-5 Year Diluted EPS CAGR15.0% over 5 years✓Neff7%-20% annualized - Efficiency63% pass✓ 8✗ 3▾
5 of 8 pass — Graham, Piotroski and Dreman object
Current Ratio0.89✗Graham>= 2.0ROIC (3-5 yr avg)84.0%✓Buffett> 10%ROIC - WACC+74.0%✓BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)63.1%✓Greenblatt> 25%Current Ratio Change YoY0.84 -> 0.88✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY1.08x -> 0.98x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities0.89✗Dreman> 1.5Return on Invested Capital51.9%✓Munger> 15%ROIC (high and growing)FY2023: ROIC=80.6%; FY2024: ROIC=68.2%; FY2025: ROIC=51.9%✓AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC51.9% (RR=100% x ROIC=51.9%)✓AkreReinvestment Rate * ROIC > 10%ROIC (5-year)5/5 years above 12% (latest 51.9%)✓SleepROIC > 12% in a majority of years
Where It Falls Short
- Valuation models0% pass✗ 9▾
AZO overvalued: all 9 models price fair value below $3259.70 (median $1894.49)
Buffett fair value$2796.64✗Buffett-16.6% margin vs $3259.70Lynch fair value$2177.49✗Lynch-49.7% margin vs $3259.70Greenblatt fair value$1660.30✗Greenblatt-96.3% margin vs $3259.70Dreman fair value$2133.90✗Dreman-52.8% margin vs $3259.70Munger fair value$1721.17✗Munger-89.4% margin vs $3259.70Pabrai fair value$1624.70✗Pabrai-100.6% margin vs $3259.70Marks fair value$1362.09✗Marks-139.3% margin vs $3259.70Ackman fair value$1894.49✗Ackman-72.1% margin vs $3259.70Templeton fair value$1917.48✗Templeton-70.0% margin vs $3259.70 - Valuation8% pass✓ 3✗ 25▾
12 of 13 flag AZO's valuation — Graham, Lynch, Greenblatt +9 more
Net income / market capitalization+4.76%; #1759/6340 (top 27.7%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPrice / 3-yr avg EPS22.9x✗Graham<= 15xPrice-to-Book Ratio✗Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)1.50✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value5.9%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=5.9%, ROC=63.1%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS22.5x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)18.0x✗Dreman< 8xPrice / Book Value per ShareN/A (negative BVPS)✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=22.5x, OE Yield=3.2%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=22.5x, FCF Yield=3.4%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=22.5x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-52.8% (IV=$2133.90 vs Price=$3259.70)✗Marks>= 20% below intrinsic valuePrice / FCF per Share31.4x✗Ackman<= 25Price vs. Trailing Low112% of trailing low ($2913.28)✓Templeton<= 120% of trailing low (certified split-adjusted live window)Positive book equity / market capitalization-0.0531; #5600/6449 (top 86.8%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS22.5x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per ShareN/A (non-positive TBVPS)✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.3610; #3063/5247 (top 58.4%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+3.41%; #1952/4519 (top 43.2%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-4.98%; #3131/6202 (top 50.5%)✗OshaughnessyTop 10% of eligible cross-section - Debt & Leverage17% pass✓ 2✗ 13▾
10 of 12 flag AZO's debt & leverage — Graham, Buffett, Lynch +7 more
LT Debt vs Net Current AssetsLT Debt $9.0B vs NCA $-1.1B✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: N/A (negative equity), IC: 8.7x✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / EquityN/A (negative equity)✗Lynch< 0.33Cash - Long-term Debt$-8.8B✗LynchPositive preferredLT Debt / Total Assets Change52.54% -> 45.46%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities0.89✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00xDebt LevelsN/A (non-positive equity)✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=8.7x, D/EBITDA=2.1x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity✗Ackman<= 1.0Negative debt-to-equity (higher means less debt)✗AsnessTop 30% of eligible cross-section - Profitability25% pass✓ 19✗ 16▾
12 of 16 flag AZO's profitability — Buffett, Lynch, Greenblatt +9 more
Net income / market capitalization+4.76%; #1759/6340 (top 27.7%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive EPS (10 years)28/28 years positive✓GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)8251.9%✓Graham>= 33% growthNet Income Positive (10+ years)28/28 years positive✓BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)149.8%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)19.1% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$2.0B✓BuffettPositive and growingEarnings Variance (10-yr CoV)1.13✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)1.50✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR15.0%✓Lynch15-30% (Fast Grower); > 0% to passROEN/A (negative equity)✗Lynch> 15%EBIT / Enterprise Value5.9%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=5.9%, ROC=63.1%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets12.91%✓PiotroskiROA > 0ROA Change YoY15.50% -> 12.91% (delta: -2.59%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=16.11%, ROA=12.91%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY53.1% -> 52.6%✗PiotroskiImproved YoYPre-Tax Income / Revenue16.5%✓Dreman>= 8%Net Income / Shareholders' Equity✗Dreman> 12%Margin of SafetyP/E=22.5x✗PabraiP/B < 1.5 or P/E < 15Return on Equity182.8% (3-yr avg)✓AkreROE > 20% (3-year avg)Discount to Intrinsic Value-52.8% (IV=$2133.90 vs Price=$3259.70)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency28/28 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue19.1%✓Ackman>= 15%Net Income / Shareholders Equity✗Ackman>= 15%5-Year EPS CAGR15.0% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Operating Margin Trend19.9% (2023) -> 19.1% (2025)✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 52.0% -> 52.6%, operating margin 19.9% -> 19.1%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingGross profit / total assets+51.49%; #642/3702 (top 17.3%)✓AsnessTop 30% of eligible cross-sectionNet income / positive book equity✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0111; #899/5884 (top 15.3%)✓AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR15.0% over 5 years✓Neff7%-20% annualizedPositive Diluted-EPS Years10/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule) - Verdicts27% pass✓ 3✗ 8▾
Split decision: 8 FAIL · 6 NEUTRAL · 1 PASS · 1 BUY
Overall verdict✗GrahamFAIL (3/9)•BuffettNEUTRAL (6/9)✗LynchFAIL (2/7)✓GreenblattRank #486•PiotroskiNEUTRAL (F-Score 6)✗DremanFAIL (4/11)•MungerNEUTRAL (3/4)✗PabraiFAIL (1/3)•AkreNEUTRAL (4/6)✗MarksFAIL (3/5)✓AckmanPASS (5/9)✗TempletonFAIL (3/8)✓SleepBUY (5/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (3/6)✗SchlossFAIL (1/7)•OshaughnessyNEUTRAL (Not ranked) - Cash Flow50% pass✓ 6✗ 6▾
5 of 10 pass — Lynch, Dreman, Pabrai +2 more object
Free Cash Flow Proxy$2.0B✓BuffettPositive and growingFCF Positive and Growing$1.8B✗LynchPositive and growingOperating Cash Flow$3.1B✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=16.11%, ROA=12.91%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)18.0x✗Dreman< 8xP/E or FCF YieldP/E=22.5x, FCF Yield=3.4%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive18/18 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap3.2%✗Ackman>= 4%Price / FCF per Share31.4x✗Ackman<= 25Positive Operating Cash Flow frequency27/27 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$1.8B✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+3.41%; #1952/4519 (top 43.2%)✗OshaughnessyTop 10% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 3.1% of shares last year, 9.7% over two.
- Buybacks
- $1.6B
- Dividends
- —
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | Q3 FY 2026 2026-02-15 – 2026-05-09 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization, capex, buybacks. | Q2 FY 2026 2025-11-23 – 2026-02-14 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization, capex, buybacks. | Q1 FY 2026 2025-08-31 – 2025-11-22 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|
| Market Cap | $52.5Bcurrent | -- | -- | $63.9Best. | $59.6Best. | $52.8Best. | $50.6Best. | $45.3Best. |
| Revenue | $4.8B↑8% | $4.3B↑8% | $4.6B↑8% | $18.9B↑2% | $18.5B↑6% | $17.5B↑7% | $16.3B↑11% | $14.6B |
| Operating Income | $923.8M↑7% | $698.5M↓1% | $784.2M↓7% | $3.6B↓5% | $3.8B↑9% | $3.5B↑6% | $3.3B↑11% | $2.9B |
| Net Income | $641.5M↑5% | $468.9M↓4% | $530.8M↓6% | $2.5B↓6% | $2.7B↑5% | $2.5B↑4% | $2.4B↑12% | $2.2B |
| EPS (Diluted) | $38.07↑8% | $27.63↓2% | $31.04↓5% | $144.87↓3% | $149.55↑13% | $132.36↑13% | $117.19↑23% | $95.19 |
| Gross Margin | 52.2%↓1% | 52.5%↓3% | 51.0%↓4% | 52.6%↓1% | 53.1%↑2% | 52.0% | 52.1%↓1% | 52.8% |
| Operating Margin | 19.1%↓2% | 16.3%↓9% | 16.9%↓14% | 19.1%↓7% | 20.5%↑3% | 19.9%↓1% | 20.1% | 20.1% |
| ROE | — | — | — | -73.2%↓31% | -56.1%↑4% | -58.1%↑15% | -68.7%↑43% | -120.7% |
| Total Debt | $9.1B↑2% | $9.0B↓2% | $8.7B↓4% | $8.9B↓3% | $9.1B↑18% | $7.8B↑25% | $6.2B↑16% | $5.4B |
| Shareholders' Equity | -$2.8B↑30% | -$2.9B↑35% | -$3.2B↑31% | -$3.4B↑28% | -$4.7B↓9% | -$4.3B↓23% | -$3.5B↓97% | -$1.8B |
| Current Ratio | 0.89↑6% | 0.89↑6% | 0.86↑3% | 0.88↑5% | 0.84↑5% | 0.80↑3% | 0.77↓11% | 0.87 |
| Debt / Equity | -3.25↓45% | -3.08↓51% | -2.69↓38% | -2.61↓36% | -1.92↓8% | -1.78↓2% | -1.76↑41% | -2.98 |
| Operating Cash Flow | $802.0M↑4% | $373.4M↓36% | $944.2M↑16% | $3.1B↑4% | $3.0B↑2% | $2.9B↓8% | $3.2B↓9% | $3.5B |
| Free Cash Flow | $456.5M↑8% | $35.6M↓88% | $630.0M↑12% | $1.8B↓7% | $1.9B↓10% | $2.1B↓16% | $2.5B↓12% | $2.9B |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Retail
AZO vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COSTCO WHOLESALE CORP /NEWCOST | $490.2B | $1106.21 | $275.2B | $8.1B | 27.8% | 0.20 | 3.8% | 1.03 | 2/9 | 5/9 | 6/7 | 1/3 | F-Score 6 | 3/11 |
| HOME DEPOT, INC.HD | $347.9B | $348.69 | $164.7B | $14.2B | 110.5% | 4.00 | 12.7% | 1.06 | 3/9 | 5/9 | 3/7 | 1/3 | F-Score 4 | 3/11 |
| TJX COMPANIES INC /DE/TJX | $148.4B | $134.37 | $60.4B | $5.5B | 53.9% | 0.28 | — | 1.14 | 3/9 | 6/9 | 7/7 | 1/3 | F-Score 7 | 4/11 |
| FASTENAL COFAST | $63.3B | $55.19 | $8.2B | $1.3B | 31.9% | 0.03 | 20.2% | 4.85 | 4/9 | 7/9 | 5/7 | 1/3 | F-Score 7 | 5/11 |
| KROGER COKR | $41.8B | $70.80 | $147.6B | $1.0B | 17.1% | 2.68 | 1.3% | 0.80 | 3/9 | 4/9 | 3/7 | 0/3 | F-Score 7 | 3/11 |
| WILLIAMS SONOMA INCWSM | $29.9B | $254.05 | $7.8B | $1.1B | 52.3% | — | 18.1% | 1.39 | 3/9 | 6/9 | 3/7 | 1/3 | F-Score 5 | 3/11 |
| CASEYS GENERAL STORES INCCASY | $26.3B | $712.08 | $17.6B | $714.4M | 18.1% | 0.62 | — | 1.01 | 3/9 | 3/9 | 2/7 | 0/3 | F-Score 9 | 3/11 |
| DILLARD'S, INC.DDS | $9.7B | $622.64 | $6.6B | $570.2M | 32.1% | 0.00 | — | 2.65 | 4/9 | 3/9 | 3/7 | 1/3 | F-Score 7 | 8/11 |